Document Type
Article
Publication Title
Journal of Law, Medicine and Ethics
Abstract
This article reviews the history and current evidence of systematic pharmaceutical industry corruption. It draws on studies by the OECD on international corruption; reports of the Securities and Exchange Commission; studies of the Public Citizen health Research Group of settlement agreements between federal and state authorities and pharmaceutical firm; the history of the Medicare and Medicaid Anti-Kickback Act; professional and industry codes of ethics; the literature on institutional corruption; and studies of conflicts of interest. These sources support findings of systemic corruption since the mid-20th century. The paper also explores the relationship between classic corruption, institutional corruption and conflicts of interest in medicine and pharmaceutical policy.
Publication Date
Spring 2026
Recommended Citation
Rodwin, Marc A., "Probing the Prevalence of Pharmaceutical Corruption" (2026). Suffolk University Law School Faculty Works. 394.
https://dc.suffolk.edu/suls-faculty/394
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.